CIS
PBYI icon

Capital International Sarl’s Puma Biotechnology PBYI Stock Holding History

Capital International Sarl’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-108,005
Closed -$8.47M – 159
2015
Q4 		$8.47M Sell
108,005
-1,400
-1% -$110K 0.72% 51
2015
Q3 		$8.24M Buy
109,405
+45,000
+70% +$4.26M 0.74% 46
2015
Q2 		$7.52M Buy
64,405
+5,765
+10% +$1.04M 0.56% 62
2015
Q1 		$13.8M Buy
58,640
+4,940
+9% +$1.06M 1.01% 38
2014
Q4 		$10.2M Buy
+53,700
New +$11.9M 0.63% 56

Other funds holding PBYI

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Capital International Sarl's PBYI Position: Q1 2016 in Review

Capital International Sarl sold out of Puma Biotechnology (PBYI) in Q1 2016, closing a stake of 108,005 shares — an estimated $8.47M sold.

Capital International Sarl first reported a position in PBYI in Q4 2014 and held it in 5 quarters. The position peaked at $13.8M in Q1 2015. 119 funds tracked by Wall St. Rank hold PBYI as of Q1 2016.

  • Capital International Sarl reported no remaining Puma Biotechnology position as of Q1 2016 after selling out during the quarter.
  • Capital International Sarl sold 108,005 Puma Biotechnology shares in Q1 2016, an estimated $8.47M.
  • Capital International Sarl first reported a position in Puma Biotechnology in Q4 2014 and held it in 5 quarters.
  • Capital International Sarl's Puma Biotechnology position peaked at $13.8M in Q1 2015.
  • 119 funds tracked by Wall St. Rank held Puma Biotechnology as of Q1 2016.

Based on Capital International Sarl's 13F filing for Q1 2016, filed 16 May 2016.